Determination of Plasma Concentrations of Dapsone, Monoacetyl Dapsone and Pyrimethamine in Human Subjects Dosed with Maloprim
Overview
Authors
Affiliations
A high-performance liquid chromatographic method was developed to enable dapsone, monoacetyl dapsone and pyrimethamine to be measured simultaneously in plasma samples from volunteers in England and Malaysia who had been dosed with Maloprim. Mean half-lives of 25 and 80 h were calculated for dapsone and pyrimethamine, respectively, but there was wide individual variation. All subjects were found to be classifiable as "slow acetylators".
Agomo C, Oyibo W, Odukoya-Maije F Malar Res Treat. 2012; 2011:932895.
PMID: 22312575 PMC: 3265291. DOI: 10.4061/2011/932895.
Klinker H, Langmann P, Richter E Antimicrob Agents Chemother. 1996; 40(7):1623-7.
PMID: 8807051 PMC: 163384. DOI: 10.1128/AAC.40.7.1623.
Opravil M, Joos B, Luthy R Antimicrob Agents Chemother. 1994; 38(5):1197-9.
PMID: 8067765 PMC: 188179. DOI: 10.1128/AAC.38.5.1197.
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
Ahmad R, Rogers H Br J Clin Pharmacol. 1980; 10(5):519-24.
PMID: 7437265 PMC: 1430153. DOI: 10.1111/j.1365-2125.1980.tb01798.x.
Salivary elimination of pyrimethamine.
Ahmad R, Rogers H Br J Clin Pharmacol. 1981; 11(1):101-2.
PMID: 7213501 PMC: 1401699. DOI: 10.1111/j.1365-2125.1981.tb01114.x.